Flucloxacillin
Spezifikationen
5250-39-5CAS-Nummer
226-051-0EG-Nummer
(2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidIUPAC-Name
C19H17ClFN3O5SChemische Formel
453.9 g/molMolekulargewicht
Flucloxacillin; FLOXACILLIN; 5250-39-5; flucloxacilina; Flucloxacilline; Flucloxacillinum; BRL 2039; 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillin; BRL-2039; CHEBI:5098; (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; DTXSID8023056; 43B2M34G2V; (2S,5R,6R)-6-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-amido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Fluorochloroxacillin; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2S(2alpha,5alpha,6beta)); 6-(3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; ABBOFLOX; STAPHLIPEN; (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; flucloxacillina; Flucloxin; Galfloxin; Rimaflox; (2S,5R,6R)-6-(((3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-((3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-(3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-amido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 6-[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Fluclomix-250; Fluclomix-500; Zoxin 250; Zoxin 500; RefChem:140784; DTXCID203056; J01CF05; 226-051-0; Floxacillin [USAN]; flucloxacillin sodium; Flucloxacilina [INN-Spanish]; Flucloxacilline [INN-French]; Flucloxacillinum [INN-Latin]; Flucloxacillin-Sodium; Floxacillin (USAN); Flucloxacillin (INN); Flucloxacillin [INN]; Floxapen (TN); (2S,5R,6R)-6-[[3-(2-chloro-6-fluoro-phenyl)-5-methyl-isoxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; C19H17ClFN3O5S; Floxacillin sodium anhydrous; Flucloxacillin sodium anhydrous; NSC277175; NSC-277175; EINECS 226-051-0; UNII-43B2M34G2V; FLOXACILLIN [MI]; Epitope ID:117416; SCHEMBL3823; FLUCLOXACILLIN [MART.]; CHEMBL222645; orb1982146; FLUCLOXACILLIN [WHO-DD]; GTPL10910; BRL2039; HY-A0246; BDBM50370590; EBC-27137; AF45048; DB00301; NCGC00485420-01; (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methylisoxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-, monosodium salt, [2S-(2.alpha.,5.alpha.,6.beta.)]-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,6-[[[3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]-3,3-dimethyl-7-oxo-,(2S,5R,6R)-; 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido]-2,2-dimethylpenam-3alpha-carboxylic acid; DA-63472; NCI60_002254; CS-0017591; NS00081140; D04196; T75277; EN300-19766067; Q1994556; BRD-K27871792-001-01-8; BRD-K27871792-236-01-0; (2S,5R,6R)-6-[3-(2-Chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLIC ACID, 6-(((3-(2-CHLORO-6-FLUOROPHENYL)-5-METHYL-4-ISOXAZOLYL)CARBONYL)AMINO)-3,3-DIMETHYL-7-OXO-, (2S(2.ALPHA.,5.ALPHA.,6.BETA.))Synonyme
